Journal Clubs
The ACR provides opportunities for examining and discussing the latest in rheumatology practice and research through a variety of journal club features.
Arthritis & Rheumatology Journal Club
These monthly features of Arthritis & Rheumatology (A&R) are written by the authors of a research study published in that month’s issue of A&R and present a brief summary of the study along with questions to guide discussion of the study’s methodology and applicability to practice. A&R journal clubs are published in the front matter of each monthly A&R issue.
See Current A&R Journal Club Article
Proinflammatory Dietary Pattern and the Risk of Female Gout
Arthritis Care & Research Journal Club
On a bimonthly basis, the authors of a selected clinical study published in Arthritis Care & Research (AC&R) create a set of PowerPoint (PPT) slides that can be used to lead a journal club discussion. Each slide deck presents a summary of the background, study methods, main results, and discussion points for the selected AC&R study. Slide decks can be downloaded for free from the supplementary information of the article.
Download Current AC&R Journal Club PowerPoint
Survival in Immune Checkpoint Inhibitor–Treated Patients With Rheumatoid Arthritis and Non–Small Cell Lung Cancer
Global Journal Club Webinars
As part of the Global Webinar Series, a quarterly virtual educational series for a global audience of rheumatologists and rheumatology health professionals. Global Journal Club sessions are facilitated discussions of recent and impactful articles in the field of rheumatology, fostering a global exchange of knowledge and ideas.
Register for the Next Webinar!
September 17 | 7:00–8:00 PM ET
In this webinar, we will discuss two recent and impactful articles published in Arthritis & Rheumatology with the authors:
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis
Joshua F. Baker MD, MS
Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center and the University of Pennsylvania, Philadelphia
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-Based Target Trial Emulation
Karen H. Costenbader MD, MPH
Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
Don't miss this opportunity to gain valuable insights in this interactive session featuring top experts in the field!
Register for Global Journal Club Webinar
Registration is complimentary, but required.